Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs.
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced*; D003891:Desipramine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D007035:Hypothermia / Q000139:chemically induced*; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009538:Nicotine / Q000037:antagonists & inhibitors; D009539:Nicotinic Acids / Q000037:antagonists & inhibitors; D009596:Nitrophenols / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors*; D010756:Phosphoric Acids / Q000494:pharmacology; D010862:Pilocarpine / Q000037:antagonists & inhibitors; D011220:Pralidoxime Compounds / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D014203:Tremorine / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D006584:Hexamethonium Compounds; D009539:Nicotinic Acids; D009596:Nitrophenols; D010276:Parasympatholytics; D010277:Parasympathomimetics; D010756:Phosphoric Acids; D011220:Pralidoxime Compounds; D010862:Pilocarpine; D000639:Amitriptyline; D009538:Nicotine; D001285:Atropine; D012601:Scopolamine; D007099:Imipramine; D003891:Desipramine; D014203:Tremorine